Literature DB >> 7875271

Improved detection of abnormal respiratory function using forced expiration from raised lung volume in infants with cystic fibrosis.

D J Turner1, C J Lanteri, P N LeSouef, P D Sly.   

Abstract

The raised volume rapid thoracic compression (RVRTC) technique is a recently developed method of measuring lung function in infants. The measurements of forced expiratory volume-time (FEVt) parameters from raised lung volumes have been shown to be less variable than maximal flow at functional residual capacity (VmaxFRC), obtained from the conventional rapid thoracic compression (RTC) technique. Measurements of VmaxFRC are highly variable, and may not be sensitive enough to detect a difference between normal infants and infants with cystic fibrosis (CF). The aim of this study was to determine whether the raised volume rapid thoracic compression technique could detect abnormal lung function in a group of CF infants with no current respiratory symptoms. Twelve CF infants were studied (median age 10.5 months, range 3-18 months), and compared to normative data collected previously on 26 healthy infants (median age 14 months, range 3-23 months). We found that VmaxFRC failed to detect any difference between the two groups. CF infants had significantly smaller FEV0.5 and FEV0.75 measurements at a lung volume set by 17.5 cmH2O predetermined inflation pressure (PP) both as raw values and when expressed as percentage predicted. We conclude that the raised volume rapid thoracic compression technique is a sensitive tool, able to detect abnormal lung function in infants with cystic fibrosis. This abnormality was not demonstrated by measurements derived from the conventional rapid thoracic compression technique in the tidal volume range.

Entities:  

Mesh:

Year:  1994        PMID: 7875271

Source DB:  PubMed          Journal:  Eur Respir J        ISSN: 0903-1936            Impact factor:   16.671


  11 in total

Review 1.  Pediatric origins of adult lung disease. 1. The contribution of airway development to paediatric and adult lung disease.

Authors:  S Stick
Journal:  Thorax       Date:  2000-07       Impact factor: 9.139

2.  Bronchodilator responsiveness in wheezy infants and toddlers is not associated with asthma risk factors.

Authors:  Jason Debley; Sanja Stanojevic; Amy G Filbrun; Padmaja Subbarao
Journal:  Pediatr Pulmonol       Date:  2011-10-17

3.  Correlation of forced oscillation technique in preschool children with cystic fibrosis with pulmonary inflammation.

Authors:  S Brennan; G L Hall; F Horak; A Moeller; P M C Pitrez; A Franzmann; S Turner; N de Klerk; P Franklin; K R Winfield; E Balding; S M Stick; P D Sly
Journal:  Thorax       Date:  2005-02       Impact factor: 9.139

4.  Early detection of cystic fibrosis lung disease: multiple-breath washout versus raised volume tests.

Authors:  Sooky Lum; Per Gustafsson; Henrik Ljungberg; Georg Hülskamp; Andrew Bush; Siobhán B Carr; Rosemary Castle; Ah-Fong Hoo; John Price; Sarath Ranganathan; John Stroobant; Angie Wade; Colin Wallis; Hilary Wyatt; Janet Stocks
Journal:  Thorax       Date:  2006-11-22       Impact factor: 9.139

5.  Nasal versus oronasal raised volume forced expirations in infants--a real physiologic challenge.

Authors:  Mohy G Morris
Journal:  Pediatr Pulmonol       Date:  2012-02-10

Review 6.  Monitoring early inflammation in CF. Infant pulmonary function testing.

Authors:  Jack K Sharp
Journal:  Clin Rev Allergy Immunol       Date:  2002-08       Impact factor: 8.667

7.  Early airway infection, inflammation, and lung function in cystic fibrosis.

Authors:  G M Nixon; D S Armstrong; R Carzino; J B Carlin; A Olinsky; C F Robertson; K Grimwood; Claire Wainwright
Journal:  Arch Dis Child       Date:  2002-10       Impact factor: 3.791

8.  Lung function from infancy to school age in cystic fibrosis.

Authors:  C S Beardsmore
Journal:  Arch Dis Child       Date:  1995-12       Impact factor: 3.791

Review 9.  Endpoints for clinical trials in young children with cystic fibrosis.

Authors:  Stephanie D Davis; Alan S Brody; Mary J Emond; Lyndia C Brumback; Margaret Rosenfeld
Journal:  Proc Am Thorac Soc       Date:  2007-08-01

10.  Cystic Fibrosis Foundation evidence-based guidelines for management of infants with cystic fibrosis.

Authors:  Drucy Borowitz; Karen A Robinson; Margaret Rosenfeld; Stephanie D Davis; Kathryn A Sabadosa; Stephanie L Spear; Suzanne H Michel; Richard B Parad; Terry B White; Philip M Farrell; Bruce C Marshall; Frank J Accurso
Journal:  J Pediatr       Date:  2009-12       Impact factor: 4.406

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.